• (-)-Norepinephrine (+)-bitartrate: Benchmarking Vascular Res

  2026-06-03

  Explore the unique applications of (-)-Norepinephrine (+)-bitartrate in dissecting vascular responsiveness and adrenergic receptor signaling. This article offers an in-depth, evidence-driven perspective on optimizing experimental design for blood pressure regulation and cardiomyopathy research.

• PK/PD Analysis of Gamithromycin in Murine Pasteurella Infect

  2026-06-03

  This study establishes the pharmacokinetic/pharmacodynamic (PK/PD) relationship of Gamithromycin for Pasteurella multocida lung infections in a neutropenic mouse model, identifying the fAUC0–24/MIC ratio as the optimal efficacy predictor. These insights refine dosing strategies for veterinary respiratory disease models and support translational research on macrolide antibiotics.

• Hematoxylin and Eosin Staining Kit (K1142): Protocol and QC

  2026-06-02

  The Hematoxylin and Eosin Staining Kit (K1142) is designed for rapid, reproducible visualization of tissue and cellular morphology in research settings. It streamlines histopathological and cytological staining workflows, particularly for paraffin-embedded and frozen tissue sections. This kit is not intended for diagnostic or clinical use and should be limited to scientific research applications.

• PK/PD Analysis of Gamithromycin Against P. multocida in Mice

  2026-06-02

  This study delineates the pharmacokinetic and pharmacodynamic relationships of Gamithromycin (ML-1709460) in a neutropenic murine lung infection model challenged with Pasteurella multocida. By quantitatively linking unbound drug exposure to antibacterial efficacy, the research supports evidence-based optimization of dosing strategies for veterinary respiratory disease therapy.

• Bufalin–CRISPR Nanomedicine Reprograms Immunity in Colorecta

  2026-06-01

  Liu et al. introduce a calcium lactate nanoparticle system co-delivering bufalin and CRISPR/Cas9 RNPs targeting CD47, inducing both pyroptosis and apoptosis in colorectal cancer cells while reprogramming tumor-associated macrophages for enhanced antitumor immunity. Their multimodal approach highlights a promising direction for overcoming immune resistance in colorectal cancer therapy.

• Gamithromycin (ML-1709460): Translational Leverage in Respir

  2026-06-01

  This thought-leadership article explores the mechanistic and translational impact of Gamithromycin (ML-1709460), delving into its unique PK/PD profile, enhanced serum potency, and evolving evidence base in both respiratory and mastitis pathogen research. Integrating recent susceptibility data, it offers actionable guidance for researchers designing in vitro and in vivo studies, highlights differentiation from conventional macrolides, and provides a strategic outlook for advancing veterinary infectious disease models.

• Applied Workflows for Ceftolozane Sulfate in Resistance Mode

  2026-05-31

  Ceftolozane sulfate stands out for its robust bactericidal activity against Pseudomonas aeruginosa and select Enterobacterales, making it a prime tool for resistance modeling and PK/PD research. This guide delivers actionable, bench-ready protocols and troubleshooting insights, translating the latest clinical and microbiological evidence into optimized experimental designs.

• Adefovir-Induced Hypophosphatemic Osteochondrosis Mimics AS

  2026-05-30

  This study presents a clinically significant case where long-term adefovir therapy for hepatitis B led to hypophosphatemic osteochondrosis, closely mimicking ankylosing spondylitis (AS). The findings highlight the importance of differentiating drug-induced bone pathology from primary inflammatory disorders using integrated clinical and laboratory assessments.

• Cyclodextrin-Mianserin HCl Complexes: Impacts on Cytotoxicit

  2026-05-29

  This study investigates the interaction between Mianserin Hydrochloride and heptakis (2,6-di-O-methyl)-β-cyclodextrin (DM-β-CD), focusing on the resulting cytotoxicity of their complexes. The findings reveal that complexation with DM-β-CD does not reduce, but rather increases, the cytotoxic effects of Mianserin HCl in vitro—contrasting with prior results using parent β-cyclodextrin.

• Perifosine (KRX-0401): Optimizing Apoptosis and Akt Pathway

  2026-05-29

  Perifosine (KRX-0401) unlocks precise inhibition of the Akt/mTOR pathway for apoptosis and radiosensitization studies in cancer and neuroprotection models. This guide delivers actionable protocols, troubleshooting tips, and a translational bridge to cutting-edge neurobiology, making it an essential resource for reproducible, quantitative research.

• Cefazedone (Refosporen): Applied Protocols & Troubleshooting

  2026-05-28

  Cefazedone (Refosporen) empowers researchers with robust, β-lactamase-resistant antibacterial activity, supporting reproducible workflows from in vitro MIC assays to advanced pharmacodynamic modeling. This guide translates recent reference findings and peer-reviewed benchmarks into actionable, data-driven protocols and troubleshooting strategies for both Gram-positive and Gram-negative infection research.

• In Vitro Activity of Temafloxacin Against Gram-Negative Bact

  2026-05-28

  This literature overview examines the in vitro antimicrobial activity of temafloxacin, a fluoroquinolone, against a broad panel of Gram-negative respiratory and urogenital pathogens. The study provides comparative MIC data versus ciprofloxacin and ofloxacin, highlighting temafloxacin's spectrum and potential for future research in resistance modeling.

• Dose- and Time-Dependent Neurotoxicity of Ibotenic Acid in M

  2026-05-27

  This study systematically elucidates the dose- and time-dependent neurotoxic effects of ibotenic acid in a murine model, revealing early biochemical and neuronal markers of toxicity. The findings provide a rigorous experimental framework for understanding glutamatergic neurotoxicity and inform the design of neurodegenerative disease models in neuroscience research.

• Sodium dicloxacillin monohydrate: Optimizing MSSA Research

  2026-05-27

  Sodium dicloxacillin monohydrate provides precision and reproducibility for researchers tackling methicillin-sensitive Staphylococcus aureus (MSSA) and Gram-positive infection models. Leveraging its tunable PK/PD profile and validated intracellular activity, this APExBIO product streamlines robust, data-driven workflows while minimizing troubleshooting hurdles.

• Chlorambucil: Mechanistic Precision and Strategy in Cancer R

  2026-05-26

  This thought-leadership article integrates mechanistic insights and translational strategy for leveraging chlorambucil—a nitrogen mustard alkylating agent—in contemporary cancer research. Drawing on in vitro assay advances and referencing Schwartz's doctoral work, it guides researchers through protocol optimization, evidence-based interpretation, and the evolving competitive landscape, while providing a forward-thinking outlook on the use of DNA crosslinking agents in translational oncology.

453 records 16/31 page Previous Next First page 上5页 1617181920 下5页 Last page